Recent acute reduction in macrolide-resistant Mycoplasma pneumoniae infections among Japanese children

Yoshitaka Nakamura1, Tomohiro Oishi2, Kazunari Kaneko3

  • 1Department of Pediatrics, Kansai Medical School, Osaka, Japan; Department of Pediatrics, Kawasaki Medical School, Okayama, Japan.

Abstract

Insights

Macrolide-resistant Mycoplasma pneumoniae (MRMP) infections in Japanese children decreased significantly after 2012. This decline is linked to shifts in antibiotic use and the prevalence of specific M. pneumoniae p1 genotypes.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Epidemiology

Background:

  • Mycoplasma pneumoniae is a common cause of pneumonia in children and young adults.
  • Understanding its prevalence and resistance patterns is crucial for public health.

Purpose of the Study:

  • To investigate the prevalence of Mycoplasma pneumoniae infections in Japanese children since 2008.
  • To analyze trends in macrolide-resistant M. pneumoniae (MRMP) and p1 genotypes.

Main Methods:

  • Nasopharyngeal swabs were collected from pediatric cases.
  • Real-time PCR was used for M. pneumoniae identification.
  • PCR restriction fragment length polymorphism typing determined p1 genotypes.

Main Results:

  • MRMP infection rates peaked at 81.8% in 2012, then declined to 14.3% by 2018.
  • The dominant p1 genotype shifted from type 1 to other types after 2012.
  • MRMP prevalence was significantly higher in type 1 isolates (82.4%) compared to other genotypes (6.5%).

Conclusions:

  • The decrease in MRMP occurrence may be attributed to changes in antibiotic prescribing practices.
  • Shifts in the distribution of M. pneumoniae p1 genotypes also likely contributed to the observed decline in resistance.